Novartis Investigative Site

Grafton, Auckland 1023

0 studies enrolling now · 4 studies all time

What they study most

Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Atherosclerotic Cardiovascular Disease, Chronic Myelogenous Leukemia, Diffuse Large B-cell Lymphoma, Hypereosinophilic Syndrome, Post-menopausal Osteoporosis, Systemic Mastocytosis

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies — Completed
• Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy — Completed
• 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs — Completed